Loading…
Q32 Bio Inc. is projected to rise to $18.28 by 2027, a +17% move from its current price of $15.68. QTTB is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $14.62 | $15.69 | $16.82 | +0.04% |
| Aug 4 | $14.21 | $15.69 | $17.33 | +0.07% |
| Aug 5 | $13.90 | $15.70 | $17.72 | +0.11% |
| Aug 6 | $13.65 | $15.70 | $18.07 | +0.14% |
| Aug 7 | $13.43 | $15.71 | $18.37 | +0.18% |
| Aug 8 | $13.23 | $15.71 | $18.66 | +0.21% |
| Aug 9 | $13.06 | $15.72 | $18.92 | +0.25% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.06 | $15.72 | $18.92 | +0.25% |
| Week 2 | $12.12 | $15.76 | $20.49 | +0.50% |
| Week 3 | $11.46 | $15.80 | $21.78 | +0.75% |
| Week 4 | $10.93 | $15.84 | $22.95 | +1.01% |
| Week 5 | $10.49 | $15.88 | $24.04 | +1.26% |
| Week 6 | $10.10 | $15.92 | $25.07 | +1.51% |
| Week 7 | $9.77 | $15.96 | $26.07 | +1.77% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Q32 Bio Inc. is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti-interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata.
The company was founded in 2017 and is based in Waltham, Massachusetts.
Q32 Bio Inc. trades under the symbol QTTB and has a current price of $15.70. Its market capitalization is $266.22M and it ranks 3608.
The forecast shows the 2026 average price at $15.70, with longer-term averages projected to rise to $24.01 in 2030 and $115.47 in 2050. Additional milestone averages include $68.54 in 2040, with a bullish outlook evident in multiple years.
Forecasted sentiment shifts from Neutral in early years (2026) to Bullish in later years, with ROIs rising from 0% in 2026 to multi-year highs (e.g., 52.9% in 2030 and 635.5% by 2050).
A major floor 68.6% below — a decisive break under it would weaken the trend.
The nearest floor, 28.8% below — buyers have tended to step in here.
The nearest ceiling, 36.4% above — a clean break opens room to run.
A major ceiling 67.7% above — clearing it would confirm fresh momentum.
Key QTTB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of QTTB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.36 | Buy | $15.42 | Buy |
| MA 10 | $15.29 | Buy | $15.32 | Buy |
| MA 20 | $15.15 | Buy | $14.88 | Buy |
| MA 50 | $13.02 | Buy | $12.93 | Buy |
| MA 100 | $9.53 | Buy | $10.46 | Buy |
| MA 200 | $6.46 | Buy | $8.29 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.15 | Neutral |
| Stoch RSI (14) | 31.05 | Neutral |
| CCI (20) | 28.92 | Neutral |
| Williams %R (14) | -72.77 | Info |
| MACD (12,26,9) | -0.17 | Sell |
| ROC (12) | -0.13 | Sell |
| Bollinger %B (20,2) | 0.57 | Neutral |
| Stochastic %K (14) | 27.23 | Neutral |
| TRIX (15) | 0.99 | Buy |
| Awesome (5,34) | 1.26 | Buy |
| Ultimate (7,14,28) | 48.10 | Neutral |
| Momentum (10) | 0.63 | Buy |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 15.37 | Buy |
| ADX (14) | 13.37 | Neutral |
| ATR (14) | 0.92 | Info |
The near-term technical picture is bullish in sentiment. RSI14 is 60, with price momentum supported by a 50-day simple moving average of $10.71 and a 200-day simple moving average of $5.70.
Key support is located at $11.16 and resistance at $21.38, framing the near-term trading range. The 30-day range spans from $8.27 to $29.82, indicating meaningful volatility within a compressed time frame. Annualized volatility sits at 200%, underscoring the potential for rapid price moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.33 | $15.68 | $21.60 | 0% | Neutral | |
| $13.31 | $18.28 | $27.13 | +17% | Neutral | |
| $11.70 | $17.09 | $27.06 | +9% | Neutral | |
| $9.55 | $14.70 | $24.45 | -6% | Neutral | |
| $11.67 | $18.83 | $32.61 | +20% | Bullish | |
| $12.05 | $20.32 | $36.45 | +30% | Bullish | |
| $13.84 | $24.35 | $45.03 | +55% | Bullish | |
| $17.07 | $31.27 | $59.45 | +99% | Bullish | |
| $15.37 | $29.30 | $57.13 | +87% | Bullish | |
| $14.61 | $28.94 | $57.74 | +85% | Bullish | |
| $20.27 | $45.04 | $98.79 | +187% | Bullish | |
| $29.24 | $64.98 | $149.45 | +314% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.33 | $15.68 | $18.35 | +0.00% |
| September 2026 | $12.64 | $15.39 | $19.56 | -1.87% |
| October 2026 | $13.13 | $16.20 | $21.00 | +5.28% |
| November 2026 | $12.77 | $15.93 | $20.99 | -1.64% |
| December 2026 | $12.82 | $16.17 | $21.60 | +1.46% |
Click any year to see its month-by-month QTTB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect QTTB to range from $3.33 to $21.60 through 2026. The $15.68 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The QTTB price prediction for 2027 points to an average of $18.28 (low $13.31, high $27.13) — a potential gain of +17% on today's $15.68. A consolidation phase looks the most probable path here.
In 2028, QTTB is projected to trade between $11.70 and $27.06, averaging $17.09 — a potential gain of +9% from today's $15.68. That is -7% versus the projected 2027 average. Price action looks broadly range-bound.
Q32 Bio Inc.'s 2029 outlook centres on $14.70, within a $9.55 to $24.45 range. That is -14% versus the projected 2028 average. That marks a -6% change versus current levels. A consolidation phase looks the most probable path here.
By 2030, QTTB could reach as high as $32.61, with a base case around $18.83 and support toward $11.67 — roughly +20% from $15.68. Momentum favours further upside here.
Expect QTTB to range from $12.05 to $36.45 through 2031. The $20.32 average target implies a +30% move from current prices. That is up +8% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The QTTB price prediction for 2032 points to an average of $24.35 (low $13.84, high $45.03) — a potential gain of +55% on today's $15.68. Momentum favours further upside here.
In 2033, QTTB is projected to trade between $17.07 and $59.45, averaging $31.27 — a potential gain of +99% from today's $15.68. That is up +28% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Q32 Bio Inc.'s 2034 outlook centres on $29.30, within a $15.37 to $57.13 range. That is -6% versus the projected 2033 average. That marks a +87% change versus current levels. Momentum favours further upside here.
By 2035, QTTB could reach as high as $57.74, with a base case around $28.94 and support toward $14.61 — roughly +85% from $15.68. Buyers look set to stay in control over this stretch.
Expect QTTB to range from $20.27 to $98.79 through 2040. The $45.04 average target implies a +187% move from current prices. That is up +56% on the projected 2035 average. Momentum favours further upside here.
The QTTB price prediction for 2050 points to an average of $64.98 (low $29.24, high $149.45) — a potential gain of +314% on today's $15.68. Buyers look set to stay in control over this stretch.
Investing $1,000 in QTTB today (≈ 63.77551 QTTB) could be worth
$4,143.97
+$3,143.97 (+314%) by 2050 · US Dollar
Based on the average projected QTTB price of $64.98 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in QTTBwould be worth at today's price.
$1,000 invested in QTTB on Jul 31, 2025 (≈ 450.450445 QTTB) would be worth
$7,063.06
+$6,063.06 (+606.3%) today · 7.06× · US Dollar
Based on a QTTB entry price of $2.22 vs. today's $15.68.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.15 | $1,034.98 | +3.5% |
| 1 month ago | $12.6 | $1,244.44 | +24.4% |
| 3 months ago | $5.04 | $3,111.11 | +211.1% |
| 6 months ago | $3.98 | $3,939.7 | +294.0% |
| 1 year ago | $2.22 | $7,063.06 | +606.3% |
| All time (5.0y) ago | $114.66 | $136.75 | -86.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our QTTB forecast.
Our base-case forecast reaches $31.00 around 2033.
Implied market cap at $31.00: $920.97M
The multi-year forecast highlights a path of growth across each subsequent year. The 2026 average price is $15.70, rising to $18.94 in 2027, $18.22 in 2028, and $17.79 in 2029, before climbing to $24.01 in 2030 and then to $28.42 (2031) and $35.05 (2032). By 2033 the average is $43.16, followed by $39.79 in 2034 and $41.13 in 2035, with further gains to $68.54 in 2040 and $115.47 in 2050.
The forecast also shows strong long-term upside in ROI: 0% in 2026, 20.6% in 2027, 16.1% in 2028, 13.3% in 2029, 52.9% in 2030, 81% in 2031, 123.2% in 2032, 174.9% in 2033, 153.4% in 2034, 162% in 2035, 336.6% in 2040, and 635.5% in 2050. Sentiment turns bullish from 2030 onward (2030–2035 and later years), reflecting a more favorable long-run outlook despite short-run variability. These are estimates and not guarantees, and actual results may differ due to market and development risks.
Tap a question to reveal the answer.
Avg $24.01; min $14.85; max $41.65; ROI 52.9%; sentiment BULLISH.
The forecast shows bullish sentiment in several years (e.g., 2030, 2031, 2032, 2033, 2034, 2035, 2040, 2050) with positive ROIs (e.g., 52.9% in 2030 and 635.5% in 2050), but 2026 shows 0% ROI, and there are years with more modest growth. These are estimates, not guarantees.
The max forecast in 2050 is $265.58, which would place it above $100.
Avg $18.94; min $13.75; max $28.20; ROI 20.6%; sentiment BULLISH.
Current price $15.70; market cap $266.22M.
Q32 Bio Inc. Community Discussion
0Share your Q32 Bio Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.